Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 208

1.

Single-Center Experience with Intimal Sarcoma, an Ultra-Orphan, Commonly Fatal Mesenchymal Malignancy.

Van Dievel J, Sciot R, Delcroix M, Vandeweyer RO, Debiec-Rychter M, Dewaele B, Cornillie J, Van Cann T, Meyns B, Schöffski P.

Oncol Res Treat. 2017;40(6):353-359. doi: 10.1159/000476036. Epub 2017 May 12.

PMID:
28501860
2.

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.

Galiè N, Jansa P, Pulido T, Channick RN, Delcroix M, Ghofrani HA, Le Brun FO, Mehta S, Perchenet L, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A.

Eur Heart J. 2017 Apr 14;38(15):1147-1155. doi: 10.1093/eurheartj/ehx025.

3.

Diagnosis of chronic thromboembolic pulmonary hypertension.

Gopalan D, Delcroix M, Held M.

Eur Respir Rev. 2017 Mar 15;26(143). pii: 160108. doi: 10.1183/16000617.0108-2016. Print 2017 Jan. Review.

4.

Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature.

Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, Pruszczyk P, Mairuhu AT, Huisman MV, Klok FA.

Eur Respir J. 2017 Feb 23;49(2). pii: 1601792. doi: 10.1183/13993003.01792-2016. Print 2017 Feb.

PMID:
28232411
5.

Systolic and diastolic unloading by mechanical support of the acute vs the chronic pressure overloaded right ventricle.

Verbelen T, Burkhoff D, Kasama K, Delcroix M, Rega F, Meyns B.

J Heart Lung Transplant. 2017 Apr;36(4):457-465. doi: 10.1016/j.healun.2016.10.003. Epub 2016 Oct 17.

PMID:
27865733
6.

BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.

Vengethasamy L, Hautefort A, Tielemans B, Belge C, Perros F, Verleden S, Fadel E, Van Raemdonck D, Delcroix M, Quarck R.

Pflugers Arch. 2016 Nov;468(11-12):1969-1983. Epub 2016 Nov 6.

PMID:
27816994
7.

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.

Mehta S, Sastry BK, Souza R, Torbicki A, Ghofrani HA, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O.

Chest. 2017 Jan;151(1):106-118. doi: 10.1016/j.chest.2016.08.1473. Epub 2016 Sep 23.

8.

Chronic Thromboembolic Pulmonary Hypertension. Epidemiology and Risk Factors.

Delcroix M, Kerr K, Fedullo P.

Ann Am Thorac Soc. 2016 Jul;13 Suppl 3:S201-6. doi: 10.1513/AnnalsATS.201509-621AS.

PMID:
27571001
9.

Right ventricular and pulmonary vascular reserve in asymptomatic BMPR2 mutation carriers.

Claessen G, La Gerche A, Petit T, Gillijns H, Bogaert J, Claeys M, Dymarkowski S, Claus P, Delcroix M, Heidbuchel H.

J Heart Lung Transplant. 2017 Feb;36(2):148-156. doi: 10.1016/j.healun.2016.06.018. Epub 2016 Jun 24.

PMID:
27475894
10.

Osteopontin, a Key Mediator Expressed by Senescent Pulmonary Vascular Cells in Pulmonary Hypertension.

Saker M, Lipskaia L, Marcos E, Abid S, Parpaleix A, Houssaini A, Validire P, Girard P, Noureddine H, Boyer L, Vienney N, Amsellem V, Marguerit L, Maitre B, Derumeaux G, Dubois-Rande JL, Jourdan-Lesaux C, Delcroix M, Quarck R, Adnot S.

Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1879-90. doi: 10.1161/ATVBAHA.116.307839. Epub 2016 Jul 21.

PMID:
27444202
11.

Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension.

Parpaleix A, Amsellem V, Houssaini A, Abid S, Breau M, Marcos E, Sawaki D, Delcroix M, Quarck R, Maillard A, Couillin I, Ryffel B, Adnot S.

Eur Respir J. 2016 Aug;48(2):470-83. doi: 10.1183/13993003.01448-2015. Epub 2016 Jul 13.

PMID:
27418552
12.

Letter by Belge et al Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models".

Belge C, Quarck R, Delcroix M.

Circulation. 2016 Apr 5;133(14):e591. doi: 10.1161/CIRCULATIONAHA.115.018683. No abstract available.

13.

Extracellular Calpain/Calpastatin Balance Is Involved in the Progression of Pulmonary Hypertension.

Wan F, Letavernier E, Abid S, Houssaini A, Czibik G, Marcos E, Rideau D, Parpaleix A, Lipskaia L, Amsellem V, Gellen B, Sawaki D, Derumeaux G, Dubois-Randé JL, Delcroix M, Quarck R, Baud L, Adnot S.

Am J Respir Cell Mol Biol. 2016 Sep;55(3):337-51. doi: 10.1165/rcmb.2015-0257OC.

PMID:
26974350
14.

Single Nucleotide Polymorphisms in IL17A and IL6 Are Associated with Decreased Risk for Pulmonary Tuberculosis in Southern Brazilian Population.

Milano M, Moraes MO, Rodenbusch R, Carvalho CX, Delcroix M, Mousquer G, Laux da Costa L, Unis G, Dalla Costa ER, Rossetti ML.

PLoS One. 2016 Feb 3;11(2):e0147814. doi: 10.1371/journal.pone.0147814. eCollection 2016.

15.

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D'Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Jaïs X, Ambroz D, Treacy C, Morsolini M, Jenkins D, Lindner J, Dartevelle P, Mayer E, Simonneau G.

Circulation. 2016 Mar 1;133(9):859-71. doi: 10.1161/CIRCULATIONAHA.115.016522. Epub 2016 Jan 29.

16.

Selexipag for the Treatment of Pulmonary Arterial Hypertension.

Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV; GRIPHON Investigators.

N Engl J Med. 2015 Dec 24;373(26):2522-33. doi: 10.1056/NEJMoa1503184.

17.

Pulmonary arterial hypertension: the burden of disease and impact on quality of life.

Delcroix M, Howard L.

Eur Respir Rev. 2015 Dec;24(138):621-9. doi: 10.1183/16000617.0063-2015. Review.

18.

Is Right Ventricular Remodeling in Pulmonary Hypertension Dependent on Etiology? An Echocardiographic Study.

Giusca S, Popa E, Amzulescu MS, Ghiorghiu I, Coman IM, Popescu BA, Delcroix M, Voigt JU, Ginghina C, Jurcut R.

Echocardiography. 2016 Apr;33(4):546-54. doi: 10.1111/echo.13112. Epub 2015 Nov 6.

PMID:
26542101
19.

Accuracy of Echocardiography to Evaluate Pulmonary Vascular and RV Function During Exercise.

Claessen G, La Gerche A, Voigt JU, Dymarkowski S, Schnell F, Petit T, Willems R, Claus P, Delcroix M, Heidbuchel H.

JACC Cardiovasc Imaging. 2016 May;9(5):532-43. doi: 10.1016/j.jcmg.2015.06.018. Epub 2015 Oct 21.

20.

Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN.

Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun FO, Mehta S, Perchenet L, Pulido T, Sastry BK, Sitbon O, Souza R, Torbicki A, Rubin LJ.

Eur Respir J. 2015 Dec;46(6):1711-20. doi: 10.1183/13993003.00364-2015. Epub 2015 Oct 22.

Supplemental Content

Loading ...
Support Center